NCT07191743 Functional Assessment in Critically Ill Patients
| NCT ID | NCT07191743 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidade Federal do Rio de Janeiro |
| Condition | Intensive Care Unit Acquired Weakness |
| Study Type | OBSERVATIONAL |
| Enrollment | 186 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 186 participants in total. It began in 2025-01-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This longitudinal, prospective observational study aims to evaluate functional status in critically ill adult patients in the Intensive Care Unit using the Chelsea Critical Care Physical Assessment Tool (CPAx). The primary objective is to analyze CPAx score variation as a potential predictor of clinical outcomes, including mortality and duration of mechanical ventilation. Functional assessments will be performed at intensive care unit (ICU) admission and discharge to monitor changes in physical function and to predict adverse clinical outcomes.
Eligibility Criteria
Inclusion Criteria: All adult patients admitted to the Pedro Ernesto University Hospital (HUPE) General ICU over 18 years of age and with an ICU stay greater than or equal to 48 hours will be included. Exclusion Criteria: * Pregnancy * Inability to record the CPAx score within the first 48 hours of ICU admission or on the day of ICU discharge * ICU readmission * Known comorbidities causing generalized weakness, such as neuromuscular or neurological diseases
Contact & Investigator
PEDRO L SILVA, PhD
STUDY DIRECTOR
Pulmonary Investigation Laboratory, Carlos Chagas Filho Institute of Biophysics (IBCCF), Federal University of Rio de Janeiro (UFRJ)
Frequently Asked Questions
Who can join the NCT07191743 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intensive Care Unit Acquired Weakness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07191743 currently recruiting?
Yes, NCT07191743 is actively recruiting participants. Contact the research team at rafaeladspaim@gmail.com for enrollment information.
Where is the NCT07191743 trial being conducted?
This trial is being conducted at Rio de Janeiro, Brazil.
Who is sponsoring the NCT07191743 clinical trial?
NCT07191743 is sponsored by Universidade Federal do Rio de Janeiro. The principal investigator is PEDRO L SILVA, PhD at Pulmonary Investigation Laboratory, Carlos Chagas Filho Institute of Biophysics (IBCCF), Federal University of Rio de Janeiro (UFRJ). The trial plans to enroll 186 participants.